BioNTech

Germany’s BioNTech, which developed COVID-19 vaccine with US giant Pfizer said it aimed to start trialling a malaria vaccine next year using the same breakthrough mRNA technology. The company said it will assess several vaccine…

Pfizer and BioNTech partners with South Africa-based company, Biovac for the production of COVID-19 vaccines for the African Union (AU). This was disclosed in  a statement published on Wednesday, the two companies said Cape Town-based…

BioNTech expects results for trial testing of COVID-19 vaccine by September, of which it and Pfizer have developed in babies as young as six months old. BioNTech Chief Executive, Ugur Sahin said, “In July, the first results could be…

Pfizer and BioNTech's COVID-19 vaccine is 100% effective against the virus in children ages 12 to 15, the companies announced in a press release on Wednesday. The vaccine is already authorized for use in people and produced…